BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37438780)

  • 1. VEGFR2 targeted microbubble-based ultrasound molecular imaging improving the diagnostic sensitivity of microinvasive cervical cancer.
    Zhong J; Su M; Jiang Y; Huang L; Chen Y; Huang Z; Zhang X
    J Nanobiotechnology; 2023 Jul; 21(1):220. PubMed ID: 37438780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound Microvessel Visualization in Cervical Cancer: Association Between Novel Ultrasound Techniques and Histologic Microvessel Densities.
    Zhong J; Huang L; Su M; Wu M; Lin X; Shui X; Jiang Y; Zhang X
    Ultrasound Med Biol; 2023 Dec; 49(12):2537-2547. PubMed ID: 37730477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional ultrasound molecular imaging of angiogenesis in colon cancer using a clinical matrix array ultrasound transducer.
    Wang H; Kaneko OF; Tian L; Hristov D; Willmann JK
    Invest Radiol; 2015 May; 50(5):322-9. PubMed ID: 25575176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound molecular imaging as a non-invasive companion diagnostic for netrin-1 interference therapy in breast cancer.
    Wischhusen J; Wilson KE; Delcros JG; Molina-Peña R; Gibert B; Jiang S; Ngo J; Goldschneider D; Mehlen P; Willmann JK; Padilla F
    Theranostics; 2018; 8(18):5126-5142. PubMed ID: 30429890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative ultrasound molecular imaging by modeling the binding kinetics of targeted contrast agent.
    Turco S; Tardy I; Frinking P; Wijkstra H; Mischi M
    Phys Med Biol; 2017 Mar; 62(6):2449-2464. PubMed ID: 28240217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microinvasive carcinoma of the uterine cervix (International Federation of Gynecology and Obstetrics Stage IA).
    Burghardt E; Girardi F; Lahousen M; Pickel H; Tamussino K
    Cancer; 1991 Feb; 67(4):1037-45. PubMed ID: 1991252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound Molecular Imaging of the Breast Cancer Neovasculature using Engineered Fibronectin Scaffold Ligands: A Novel Class of Targeted Contrast Ultrasound Agent.
    Abou-Elkacem L; Wilson KE; Johnson SM; Chowdhury SM; Bachawal S; Hackel BJ; Tian L; Willmann JK
    Theranostics; 2016; 6(11):1740-52. PubMed ID: 27570547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery.
    Bean LM; Ward KK; Plaxe SC; McHale MT
    Am J Obstet Gynecol; 2017 Sep; 217(3):332.e1-332.e6. PubMed ID: 28522318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-Low-Dose Ultrasound Molecular Imaging for the Detection of Angiogenesis in a Mouse Murine Tumor Model: How Little Can We See?
    Wang S; Herbst EB; Mauldin FW; Diakova GB; Klibanov AL; Hossack JA
    Invest Radiol; 2016 Dec; 51(12):758-766. PubMed ID: 27654582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic Modeling of Targeted Ultrasound Contrast Agents for Quantitative Assessment of Anti-Angiogenic Therapy: a Longitudinal Case-Control Study in Colon Cancer.
    Turco S; El Kaffas A; Zhou J; Lutz AM; Wijkstra H; Willmann JK; Mischi M
    Mol Imaging Biol; 2019 Aug; 21(4):633-643. PubMed ID: 30225758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effect of VEGFR2-targeted microbubble destruction with gemcitabine using an endoscopic ultrasound probe: In vivo mouse pancreatic ductal adenocarcinoma model.
    Shimamoto N; Ito M; Chiba M; Honma S; Imazu H; Sumiyama K
    Hepatobiliary Pancreat Dis Int; 2020 Oct; 19(5):478-485. PubMed ID: 32265136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor receptor type 2-targeted contrast-enhanced US of pancreatic cancer neovasculature in a genetically engineered mouse model: potential for earlier detection.
    Pysz MA; Machtaler SB; Seeley ES; Lee JJ; Brentnall TA; Rosenberg J; Tranquart F; Willmann JK
    Radiology; 2015 Mar; 274(3):790-9. PubMed ID: 25322341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical outcome of patients with stage Ia1 and Ia2 squamous cell carcinoma of the uterine cervix: a Cooperation Task Force (CTF) study.
    Gadducci A; Sartori E; Maggino T; Landoni F; Zola P; Cosio S; Pasinetti B; Alessi C; Maneo A; Ferrero A
    Eur J Gynaecol Oncol; 2003; 24(6):513-6. PubMed ID: 14658592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic properties of carcinoma in situ and microinvasive carcinoma of the uterine cervix.
    Sotiropoulou M; Diakomanolis E; Elsheikh A; Loutradis D; Markaki S; Michalas S
    Eur J Gynaecol Oncol; 2004; 25(2):219-21. PubMed ID: 15032286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model.
    Bachawal SV; Jensen KC; Lutz AM; Gambhir SS; Tranquart F; Tian L; Willmann JK
    Cancer Res; 2013 Mar; 73(6):1689-98. PubMed ID: 23328585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
    Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M
    Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and Characterization of Sentinel Lymph Node by Ultrasound Molecular Imaging with B7-H3-Targeted Microbubbles in Orthotopic Breast Cancer Model in Mice.
    Hu Z; Bachawal SV; Li X; Wang H; Wilson KE; Li P; Paulmurugan R
    Mol Imaging Biol; 2022 Apr; 24(2):333-340. PubMed ID: 34787812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Sensitivity in Ultrasound Molecular Imaging With Coherence-Based Beamforming.
    Hyun D; Abou-Elkacem L; Perez VA; Chowdhury SM; Willmann JK; Dahl JJ
    IEEE Trans Med Imaging; 2018 Jan; 37(1):241-250. PubMed ID: 29293430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo Ultrasound Molecular Imaging in the Evaluation of Complex Ovarian Masses: A Practical Guide to Correlation with Ex Vivo Immunohistochemistry.
    Antil N; Wang H; Kaffas AE; Desser TS; Folkins A; Longacre T; Berek J; Lutz AM
    Adv Biol (Weinh); 2023 Aug; 7(8):e2300091. PubMed ID: 37403275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound Molecular Imaging With BR55 in Patients With Breast and Ovarian Lesions: First-in-Human Results.
    Willmann JK; Bonomo L; Testa AC; Rinaldi P; Rindi G; Valluru KS; Petrone G; Martini M; Lutz AM; Gambhir SS
    J Clin Oncol; 2017 Jul; 35(19):2133-2140. PubMed ID: 28291391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.